At Princess Margaret Hospital is an exciting initiative, focusing on phase I and II oncology clinical trials. In addition to implementing high quality studies with novel anti-cancer agents, we will continue to provide optimal patient care. A major component of the Drug Development Program is the PMH Phase II Consortium. Details current issues and events.

The clinician scientists of the Stanford Cancer Institute. Are engaged in more than 250 clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.

An international leader in clinical trials, playing a pivotal role in developing new therapies and the advancement of patient care. Cancer Trials Australia is the partner of choice, for its members, industry and research organisations, to provide excellence in oncology clinical trials. Access to co-ordinated clinical network, advice on trial design, translational drug development and protocol development. 305 Grattan Street, Melbourne Victoria 3000. ABN 21 105 748 605.

Please contact your service provider for more details.

He Cancer Trust was founded in 2013 on a non-profit basis. It also has qualified under IRS Sec. 501 c3 as a charitable organization. We believe collaboration accelerates the anticancer drug discovery process and vastly improves the probability of finding new therapeutics. Consequently, we assemble teams of elite scientists from several different Cancer Centers who are prepared to collaborate for several years in order to access capital support in amounts unimaginable to most researchers.